Fertility Solutions Development of the year 2025 in EUROPE

Being awarded the title of Fertility Solutions Development of the Year 2025 in Europe by Life Science Reviews is a major milestone for RODI and a powerful validation of what we have built: a new, clinically driven approach to fertility support.This recognition reflects the innovation behind RODI NK plus and RODI NK, two products that have helped reshape how clinicians and patients think about fertility care, especially in the most challenging cases: unexplained infertility, recurrent miscarriage, implantation failure, and repeated IVF failure. 

Where the field has long relied on generic supplementation, RODI introduced a differentiated, science-led solution focused on immune equilibrium, designed to be integrated into real-world fertility protocols.RODI NK plus pioneered a preconception approach that supports women before pregnancy begins, while RODI NK extends that support into early pregnancy, creating a practical, protocol-based pathway that many doctors can apply even when the “why” behind infertility remains unclear. Together, these innovations have expanded the fertility toolkit with solutions that are clinically backed, patient-centered, and compatible with IVF protocols and most importantly based on natural ingredients and accordingly vegeterian. .At a time when fertility challenges are rising globally, our mission remains clear: to bridge rigorous research with everyday clinical applicability delivering solutions that are not only innovative, but meaningful for the women who need them most and are followed by clinical studies and real world post marketing results.This award reinforces our commitment to lead with innovation, quality, and trust as we continue to expand across Europe, USA and beyond setting new standards in fertility support, driven by research, guided by medical expertise, and inspired by the women we serve.